chrisvoncsefalvay/vaers-outcomes huggingface dataset:
Small pox vaccination while underway 10/6/06; 10/18 pt had generalized, diffuse itchy rash; tx with claritin and calamine lotion; 10/20 pt had headache, fatigue, vomiting, ?fever. Tx with a shot (unknown) with sx relieft. Continues with rash, headache, fatigue monthly (beginning 2-3 days prior to menses)
Initial unsolicited report received from a pharmacist via other company (Merck) (service request number: 00171545) on 20-SEP-2016. This case involves 27 year old female patient who was vaccinated with a dose Fluzone Quadrivalent (batch number, expiry date, route and site of administration: not reported), and a dose of Pneumovax 23 (manufacturer: other, batch number: M020521, expiry date: 17-NOV-2017, route and site of administration: not reported) on 25-AUG-2016. Patient had Drug reaction/ allergies to latex and other pertinent medical history was reported as none. Concomitant medications included Metadate and Jolessa. On 25-AUG-2016, same day following vaccination with Fluzone and 12 hours post Pneumovax 23 vaccination, patient developed pain at the injection site. The reporter reported that pain had continued to worsen and on an unspecified date post vaccination, the patient now had pain, swelling and a rash that extended to the elbow, was unable to use her arm due to the pain and that her arm was in a sling. It was reported that the patient required doctor visit (sought medical attention from her physician). Laboratory data was reported as none. The patient received corrective treatment (not specified). The outcome of the events was reported as not recovered. List of documents held by sender: none.
Patient received pneumovax 23 2 days ago and noticed symptoms yesterday. Reports 3-4 areas of red blotching around the site of injection with pain and warmth to touch. States she feels like it is worsening. Denies itching, difficulty breathing or fever. Patient received prevnar 13 on  8/16/17 without a reaction.
Patient received the covid vaccine on 12/28/2020.  c/o new onset of bil eyelid swelling with "greenish" discharge on 1/1/2021 and stomach pain (relieved with BM - "little diarrhea") on 1/2/2021. Diarrhea improved after 24 hours but the eye swelling persists.  On 1/5/2021 new onset of headache, vomiting, "wet" cough, and nasal congestion.  Denies fever, chills, or body ache.    Covid test on 12/28/2020 was negative.
Patient received second dose of Gardasil 9 on 8/18/2021, approx three hours after at home was noted to have involuntary twitching. Was seen in ED at Medical Center on 8/18/2021, Given Ativan, discharged home, improved, slept well, but upon awakening 8/19/2021 was noted to have the involuntary twitching again and was taken back to ED at Medical Center on 8/19/2021. Had lab work done and drug screen which was unremarkable and neuro was consulted, likely to be motor tic, advised could use Ativan and Benadryl as needed.  Discharged home, to follow up with neurology outpatient.
Patient complained of burning, itching, and redness around the injection site area that lasted for the course of about 1 week. Patient states that this occurred one day after the injection was administered.
Intermittent left shoulder ache, head ache, and fatigue began at about 48 hours after vaccination, duration was for days 3 thru 5, or approximately 72 hours. No adverse effects noted today which is day 6. Overall significant adverse effects days 2-5 but completely resolved. The vaccination was the second Moderna booster after the initial two dose Pfizer series. Adverse effects more than experienced before in a retired health professional who has had very minimal effects or no side effects with approximately 12 vaccinations from age 64 to 66, and close to 100 vaccinations lifetime.
On 10/19/2018, client report to facility for completion of TWINRIX vaccine series. Client assessed and reports that he only needed the Hepatitis B vaccine according to his University. Client was provided one dose of ENGERIX (Hepatitis B) vaccine, he did not complete the TWINRIX dose for the addition of the Hepatitis A vaccine. It has not been reported that the client had any reaction post receiving the Hepatitis B vaccine, instead of the combination of TWINRIX (Hepatitis A/B). Supervising staff notified post vaccination. TWINRIX vaccine added above, however client did not receive the vaccine. Age of patient at time of event: 28 years.
SHOOTING PAIN DOWN THE ARM; HEADACHE; FEVER; This spontaneous report received from a consumer concerned an 18 year old female. The patient's height, and weight were not reported. No past medical history or concurrent conditions were reported. The patient received covid-19 vaccine ad26.cov2.s (suspension for injection, route of admin not reported, batch number: Unknown) dose was not reported, administered on 22-JUN-2021 for prophylactic vaccination. The batch number was not reported and has been requested. No concomitant medications were reported. On JUN-2021, the subject experienced shooting pain down the arm. On JUN-2021, the subject experienced headache. On JUN-2021, the subject experienced fever. Treatment medications (dates unspecified) included: paracetamol. The action taken with covid-19 vaccine ad26.cov2.s was not applicable. The patient recovered from shooting pain down the arm, headache, and fever on JUN-2021. This report was non-serious.
Red circle at injection site on arm, swollen and warm. Appeared 6 days after vaccine.
precipitated an autoimmune condition that looks like GBS or some form thereof.; This is a spontaneous report from a contactable consumer. A male patient of an unspecified age received BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE: Lot number and expiration date were not reported), via an unspecified route of administration, on an unspecified date as unknown dose, single for COVID-19 immunization. The patient's medical history and concomitant medications were not reported. After the vaccination, the patient subsequently seems to have precipitated an autoimmune condition that looks like Gullian-barre Syndrome (GBS) or some form thereof on an unspecified date. The patient need to find a great neurologist or neuro-immunologist regarding this event. The reporter wanted to know whether any direction which can help the patient for sorting this event. The outcome of the event was unknown at the time of report.   This lot number for the vaccine BNT162B2 was not provided and will be requested during follow-up.
Information has been received from an office manager concerning a 14 year old female who on 02-Nov-2006 was vaccinated intramuscularly in the arm with a 0.5 ml dose of HPV rL1 6 11 16 18 VLP vaccine (yeast). On 03-Nov-2006 the patient started her menses and experienced a migraine. On 06-Nov-2006 the patient experienced a rash on her vaccinated arm which also spread to her face. Unspecified medical attention was sought. The patient was treated with diphenhydramine (BENADRYL) and the rash had subsided. AT the time of report, the patient was recovering from the migraine. No product quality complaint was involved. Additional information has been requested.  This is in follow-up to report (s) previously submitted on 12/14/2006.  Information has been received from an office manager concerning a 14 year old female with no pertinent medical history who on 02-NOV-2006, at 15:00, was vaccinated intramuscularly in the left arm with a 0.5 ml first dose of GARDASIL.  On 03-NOV-2006 the patient started her menses and experienced a migraine.  On 06-NOV-2006 the patient developed hives on her vaccinated arm which also spread to her face.  Unspecified medical attention was sought.  The patient was treated with BENADRYL and the rash had subsided.  At the time of report, the patient was recovering from the migraine.  Follow-up reported that the patient had a new puppy with fleas.  The pediatrician diagnosed that the rash was due to flea bites and not due to an allergy.  The patient was expected to received the second dose in January 2007.  No product quality complaint was involved.  Additional information is not available.
persistent sore throat, fatigue, & backache beginning 1mo p/vax lasting 1mo
Information has been received from a licensed practical nurse concerning a 14 month old caucasian male patient with no known medical history or allergies who on 30-MAR-2007 was vaccinated SC in the left thigh with a first dose of varicella virus vaccine live (Oka/Merck) (lot number 653966/0906F). There was not illness at the time of vaccination. Subsequently the patient developed a rash at the injection site. Unspecified medical attention was sought. No product quality complaint was involved. Information was received from licensed practical nurse reporting that on 09-APR-2007 the patient developed a reaction to varicella virus vaccine live (Oka/Merck) that was administered in the left thigh. It was reported that the left thigh had a small papule surrounded by mild redness. The patient was seen for this reaction on an unspecified date. No treatment was reported. At the time of the report the patient's recovery status was unknown. Additional information is not expected.
tested positive for Covid; tested positive for Covid; This is a spontaneous report from a Pfizer-sponsored program. A contactable female consumer (patient) an unspecified age reported that she received first dose of BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE, formulation: Solution for injection, Lot Number: Unknown, and Expiration date: Unknown), via an unspecified route of administration on 29Jul2021 as dose 1, single for COVID-19 immunization. The patient medical history and concomitant medications were not reported. It was reported that the patient tested positive for Covid on 13Aug2021. The patient missed her scheduled second dose (yesterday), on 19Aug2021. The patient wanted to know how and when she could get her second dose. The patient declined to make a report. Stated she was just trying to get information and had been on the phone awhile now. She was asking if making this call will prevent her from getting the 2nd dose. The patient underwent lab tests and procedures which included SARS-CoV-2 test (COVID test): positive on 13Aug2021. Investigation assessment was not reported. The outcome of the events was unknown.  Information on lot/batch number has been requested.
Chills beginning at 11PM day of vaccination, woke up with a 101.5 fever, throbbing headache around 4am. Began experiencing fatigue around 10am, along with body aches.
reddened area the size of a baseball (left arm; lump like an extra muscle ( left arm); This spontaneous case was reported by a patient and describes the occurrence of ERYTHEMA (reddened area the size of a baseball (left arm) and PERIPHERAL SWELLING (lump like an extra muscle ( left arm)) in a 73-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch nos. 046B21A and 046B21A) for COVID-19 vaccination.     Concomitant products included METFORMIN, ATENOLOL, SPIRONOLACTONE, LEVOTHYROXINE, OMEPRAZOLE and FISH OIL (OMEGA 3 FISH OIL [FISH OIL]) for an unknown indication, LISINOPRIL.   On 14-Apr-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 12-May-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) dosage was changed to 2 dosage form. On 12-May-2021, the patient experienced ERYTHEMA (reddened area the size of a baseball (left arm) and PERIPHERAL SWELLING (lump like an extra muscle ( left arm)). At the time of the report, ERYTHEMA (reddened area the size of a baseball (left arm) and PERIPHERAL SWELLING (lump like an extra muscle ( left arm)) outcome was unknown.        mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) dosing remained unchanged.       Treatment information not reported.
COVID-19 vaccine under Emergency Use Authorization. Healthcare professional received Pfizer-Biontech COVID vaccine, lot EK5730, on 12/16/20. Developed high grade fever for 1 day followed by significant muscle aches, headache, palpitations, nausea, and fatigue. Missed work for 4 days and went to ER on day 3. Still had some symptoms at time of report on 12/20/20.
Chest pain left side only if sleeping on my left side, spasms in my hands and all of my left side, extreme itching upper chest area only, lost sense of taste and smell intermittent, intermittent chest pain currently, and fatigue.
After the second dose a large red bump or, "Covid arm" appeared two days after the second dose.
Eight days after receiving the Moderna COVID-19 vaccine, I developed a rash at the injection site, approximately 3 inches by 2 inches in size, accompanied by soreness. I took Benadryl, which reduced the rash. It went away on its own about three days later.
8 days after vaccination developed maculopapular rash, fever joint swelling (multiple), tachycardia. Symptoms prolonged requiring hospitalization. Final diagnosis systemic onset juvenile rheumatoid arthritis. Still with JRA symptoms. 60 day follow up on 11/05/2003: "Vaccine recipient did not recover from the adverse events.  Still having acute flare of juvenile rheumatoid arthritis (systemic) requiring methotrexate and oral steroids." The discharge summary received on 1/12/04 confirms diagnosis of juvenile rheumatoid arthritis. Also add joint pain, dehydration and weight loss.
male patient received three doses of Shingrix; This case was reported by a pharmacist via call center representative and described the occurrence of extra dose administered in a 68-year-old male patient who received Herpes zoster (Shingrix) (batch number GJ549, expiry date 15th September 2023) for prophylaxis.   Previously administered products included Shingrix (1st dose received on 24th September 2021) and Shingrix (2nd dose received on 11th March 2022).   On 23rd September 2022, the patient received the 3rd dose of Shingrix. On 23rd September 2022, unknown after receiving Shingrix, the patient experienced extra dose administered. On an unknown date, the outcome of the extra dose administered was unknown.     Additional Information: GSK receipt date: 23-SEP-2022 Reporters comment: The patient received three doses of Shingrix vaccine. The reporter consent to follow-up. They received the three doses on the same day and they were a husband and wife team. Additional Supportive information: The patient received three doses of Shingrix vaccine, which led to extra dose administered. This case is linked to the case US2022137212, reported by the same reporter.; Sender's Comments:  US-GSK-US2022137212:Same reporter
Typical muscle aches; slight fever; chills; headache; Swollen painful lymph node in the left armpit.; Swollen painful lymph node in the left armpit.; This is a spontaneous report received from a contactable other health care professional(patient). A 37-year-old female patient received BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE - solution for injection; lot number: FC3182;expiry date was not reported) via an unspecified route of administration, at the left  arm, on 31Aug2021 13:00, at age of 37-year-old ,at dose 2, single for covid-19 immunisation in a pharmacy or drug store. Relevant medical history includes sulfa allergy. Concomitant medications in two weeks include multivitamin (unspecified), fish oil (OMEGA 3), and drospirenone, ethinylestradiol betadexclathrate (YAZ).Historical vaccine included BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE, solution for injection; lot number FA7484, expiry date not reported) via an unspecified route of administration, at the left  arm, on 03Aug2021,13:00, at age of 37-year-old at dose 1, single for covid-19 immunisation. The patient is not pregnant at the time of vaccination. The patient did not have other vaccine in four weeks. The patient did not have prior COVID vaccination and was not tested post vaccination. On 01Sep2021, the patient experienced typical muscle aches, slight fever, chills, headache and swollen painful lymph node in the left armpit. The patient did not receive treatment in response to the events. The outcome of the events was recovered on an unspecified date in Sep2021..
Patient received ZOSTAVAX Inj. on 3-12-12 and called on 3-13-12 stating round red rash appeared on arm at injection site. 3-14-12, pt. came back into pharm with antibiotic for cellulitis.
Presented to ED w/cp and persistent cough, sore throat & SOB; admitted for COVID-19 pna; tx w/ abx, remdesivir, steroids, pepcid, Singulair, zinc; pt did not require O2 therapy; symptoms resolved & pt dc'd home
Out of body experience, exhaustion, body aches, confusion, head aches, diarrhea
Shortly after patient was vaccinated, she started to feel an itching, tingling feeling in her throat.  Fearing that it was an allergic reaction, I called 911.  The patient remained alert, talking and breathing normally until paramedics arrived, though she stated that she started to feel additional tingling in her arms and chest.  She was transported by ambulance to emergency department. No treatment administered before paramedics arrived.
fever, headache, generalized body aches, chills, nausea, "felt horrible, awful, terrible",  sent to EC for evaluation and discharged
4OCT96 arm became sore 5OCT96 arm touched pt became nauseated; called MD instructions to do hot & cold pack;devel fever of 101 5OCT;21OCT96 arm still has hard bump;when pressed on arm goes numb;
I began feeling expected pain on the 9th but it progressively got worse each day after.  Two to three weeks later I could barely move my arm; pulling cloths (tops) off was painful.  I could not sleep on my left arm and when moving covers it was very painful and I could not do it.  I reached out to HR Dept. on 11/25/16 who in turn got me in contact with the company who administered vaccine on 11/28/16.  I went to an orthopedic on 11/30/16 who gave me a steroid shot in the area that was inflamed and referred me to physical therapy.  I am now receiving physical therapy on left shoulder - two appointments thus far.
Pt received Pfizer x2.  Pt tested COVID + on 9/9/21 and admitted to hospital for COVID on 9/16/2021. Pt receiving remdesivir and dexamethasone.
Vaccine adminsitered to patient below the age eligibility for this vaccine.  The clinic had moved from all Pfizer to all Janssen for a few days and the staff neglected to catch that she would not be 18 until December of 2021.   Identified just after vaccination.  Mother was told and explained that there was nothing she needed to do other than the usual recommended reporting of any adverse events back to us.  No further communication from patient/mother after date of service.
Sore right arm; Sored upoto her neck; This spontaneous case was reported by a consumer and describes the occurrence of PAIN IN EXTREMITY (Sore right arm) and NECK PAIN (Sored upoto her neck) in a 61-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 042L20A) for COVID-19 vaccination.     No Medical History information was reported.    On 19-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 19-Jan-2021, the patient experienced PAIN IN EXTREMITY (Sore right arm) and NECK PAIN (Sored upoto her neck). The patient was treated with PARACETAMOL (TYLENOL) at an unspecified dose and frequency. On 20-Jan-2021, NECK PAIN (Sored upoto her neck) had resolved. On 21-Jan-2021, PAIN IN EXTREMITY (Sore right arm) had resolved.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       No relevant concomitant medications were reported.   Treatment details-patient took Tylenol on 20 Jan 2021.
on day 1 she experienced lots of extreme itching all over her body, day 2 red knot in shot area and arm is red and hot to touch.
This case was reported by a pharmacist via call center representative and described the occurrence of fever in a patient who received SHINGRIX. On 7th May 2018, the patient received the 1st dose of SHINGRIX. In May 2018, less than a week after receiving SHINGRIX, the patient experienced fever, light headedness and headache. On an unknown date, the outcome of the fever, light headedness and headache were unknown. It was unknown if the reporter considered the fever, light headedness and headache to be related to SHINGRIX. Additional details were provided as follows: The age at vaccination was not reported. The patient experienced low grade fever. The pharmacist refused to provide further information regarding the adverse events as she was the only pharmacist at the pharmacy and she had to get off the phone.
red arm after the first vaccination; inflamed arm; vaccination hurt a lot; This non-serious case was reported by a consumer via interactive digital media and described the occurrence of erythema of extremities in a patient who received Herpes zoster (Shingles vaccine) for prophylaxis.   Co-suspect products included Herpes zoster (Shingles vaccine) for prophylaxis.   On an unknown date, the patient received the 2nd dose of Shingles vaccine and the 1st dose of Shingles vaccine. On an unknown date, an unknown time after receiving Shingles vaccine, the patient experienced erythema of extremities (Verbatim: red arm after the first vaccination), inflammation localized (Verbatim: inflamed arm) and pain (Verbatim: vaccination hurt a lot). The patient was treated with non-drug therapy (Ice Pack (No Medication)). The outcome of the erythema of extremities, inflammation localized and pain were not reported.   It was unknown if the reporter considered the pain to be related to Shingles vaccine. It was unknown if the reporter considered the erythema of extremities and inflammation localized to be related to Shingles vaccine.     It was unknown if the company considered the pain to be related to Shingles vaccine. It was unknown if the company considered the erythema of extremities and inflammation localized to be related to Shingles vaccine.   Additional Information: GSK receipt date: 31-Mar-2023 The case was received from the patient via interactive digital media. The patient also asked that for red and it inflamed arm after the first vaccination and the patient put ice on them. The second vaccination hurt a lot but did not swell. The patient stated that thank god. The follow-up could not be possible as no contact details were available.